Market Place
Sourcing Support
Prinston`s Generics Brexpiprazole Receives Tentative Approval in US
21 Oct 2024 //
FDA
Otsuka And Lundbeck Present REXULTI® Data At AAIC 2024
31 Jul 2024 //
BUSINESSWIRE
Otsuka Announce FDA Acceptance of sNDA for Brexpiprazole and Sertraline
25 Jun 2024 //
BUSINESSWIRE
Otsuka, Lundbeck: Brexpiprazole Plus Sertraline Data In PTSD Presented
28 May 2024 //
BUSINESSWIRE
Lundbeck blames DTC blackout for slowdown in Rexulti growth
16 May 2024 //
FIERCE PHARMA
Rexulti the surprise winner in April`s TV drug ad spending list
07 May 2024 //
FIERCE PHARMA
Otsuka, Lundbeck sNDA for Brexpiprazole+Sertraline in PTSD
09 Apr 2024 //
PRESS RELEASE
Otsuka and Lundbeck Present New Data Analyses on the Efficacy of REXULTI
18 Mar 2024 //
BUSINESSWIRE
Apotex Inc`s Generic Brexpiprazole Receives Approval in the U.S.
13 Dec 2023 //
FDA
Alkem Laboratories` Generic Brexpiprazole Receives Approval in the U.S.
28 Nov 2023 //
FDA
JAMA Neurology Publishes Complete Results of Positive Phase 3 Study of REXULTI
06 Nov 2023 //
BUSINESSWIRE
Optimus Pharma`s Generic Brexpiprazole Receives Approval in the U.S.
25 Oct 2023 //
FDA
Otsuka & Lundbeck Announce US FDA Approval of (sNDA) for REXULTI®
10 May 2023 //
BUSINESSWIRE
Otsuka, Lundbeck head into FDA panel with agency support
13 Apr 2023 //
FIERCE PHARMA
FDA backs Rexulti for first approval for agitation associated with Alzheimer’s dementia
12 Apr 2023 //
ENDPTS
Otsuka, Lundbeck eye Alzheimer`s indication in FDA adcomm
29 Mar 2023 //
ENDPTS
USFDA approves Lupin`s Brexpiprazole tablets for schizophrenia and depressio ..
22 Mar 2023 //
HEALTH ET
Alembic Pharma gets USFDA nod to market generic antidepressant drug
09 Mar 2023 //
ECONOMIC TIMES
Ajanta`s Generic Brexpiprazole Receives Approval in the U.S.
03 Feb 2023 //
FDA
Otsuka Applies for the Indication of Major Depressive Disorder for Rexulti
30 Jan 2023 //
PRESS RELEASE
MSN`s Generic Brexpiprazole Receives Approval in the U.S.
25 Jan 2023 //
FDA
Zydus` Generic Brexpiprazole Receives Approval in the U.S.
10 Jan 2023 //
FDA
FDA accepts one, delays another; Data, deals and dollars for slate of biotechs
09 Jan 2023 //
ENDPTS
Otsuka and Lundbeck Announce FDA Acceptance of sNDA for Brexpiprazole
07 Jan 2023 //
BUSINESSWIRE
Otsuka & Lundbeck Present Positive Data From Phase 3 Studies for Brexpiprazole
01 Dec 2022 //
BUSINESSWIRE
Sandoz`s Generic Brexpiprazole Receives Approval in the U.S.
26 Sep 2022 //
FDA
Zenara`s Generic Brexpiprazole Receives Approval in the U.S.
29 Aug 2022 //
FDA
Teva`s Generic Brexpiprazole Receives Approval in the U.S.
11 Aug 2022 //
FDA
Otsuka & Lundbeck shows reduced agitation treated with brexpiprazole
04 Aug 2022 //
PRESS RELEASE
Otsuka Pharma and Lundbeck present positive results showing reduced agitation
04 Aug 2022 //
BUSINESSWIRE
Otsuka Pharmaceutical and Lundbeck to Present PIII Data for Brexpiprazole
02 Aug 2022 //
BUSINESSWIRE
Lundbeck, Otsuka drug cut agitation in Alzheimer`s patients
28 Jun 2022 //
FIERCEPHARMA
FDA Accepts sNDA of Otsuka & Lundbeck; Priority Review for Schizophrenia
13 Oct 2021 //
BUSINESSWIRE
Lupin receives US FDA approval for generic Rexulti tablets
07 Oct 2021 //
PHARMABIZ
Otsuka and Sunovion Ink Neuropsychiatric Medicine Deal
01 Oct 2021 //
ENDPTS
Alkem Labs`s Generic Brexpiprazole Receives Approval In US
27 Sep 2021 //
FDA
Zydus Cadila receives tentative approval from US FDA for Brexpiprazole tablets
09 Sep 2021 //
EXPRESSPHARMA
Zydus Cadila gets US FDA tentative marketing nod for brexpiprazole tablets
09 Sep 2021 //
PHARMABIZ
Busulfex Injection 60mg Approved in Japan for Once-daily Administration
25 Aug 2021 //
THEPHARMALETTER
Otsuka Obtains Approval in Japan for Orally-Disintegrating-Dose Form
18 Aug 2021 //
FIRSTWORDPHARMA
The Danish Business Authority (“Erhvervsstyrelsen”) requires Lundbeck
27 Nov 2020 //
CISION
Lundbeck’s key products shine in Q2 but problems remain
14 Aug 2019 //
PMLIVE
Lundbeck & Otsuka`s Antipsychotic Drug Fails Two Bipolar Phase III Trials
15 Feb 2019 //
BIOSPACE
Lundbeck and Otuska’s brexpiprazole hits the mark in PTSD trial
01 Dec 2018 //
FIERCE BIOTECH
Lundbeck’s Dunsire has something to cheer as Rexulti combo shows promise in PTSD
30 Nov 2018 //
ENDPTS
Otsuka Pharma`s Rxulti(brexpiprazole) Receives Approval in Europe
27 Nov 2018 //
EMA
Brexpiprazole - Another Successful Project in API R&D
06 Jul 2018 //
PRESS RELEASE
Pfizer`s Ibrance joins February`s TV ad-spending leaders
23 Mar 2018 //
FIERCE PHARMA
Otsuka and Lundbeck revive Rexulti mask campaign as U.S. uptake soars
28 Feb 2017 //
FIERCE PHARMA
Health Canada Approves Otsuka & Lundbeck`s Rexulti
21 Feb 2017 //
BUSINESSWIRE
Otsuka Pharm`s Brexpiprazole Approved In US
23 Sep 2016 //
FDA
